Synthesis and biological activity of new resveratrol derivative and molecular docking: Dynamics studies on NFkB

Applied Biochemistry and Biotechnology

Volumn 171, Issue 7, 2013, Pages 1639-1657

  Banaganapalli, Babajan ^a,c   Mulakayala, Chaitanya ^a   Gowsia, D ^a   Mulakayala, Naveen ^b   Pulaganti, Madhusudana ^a   Shaik, Noor Ahmad ^c   Cm, Anuradha ^a   Rao, Raja Mohan ^b   Al Aama, Jumana Yousuf ^c   Chitta, Suresh Kumar ^a  

^a SRI KRISHNADEVARAYA UNIVERSITY   (India)

^b INSTITUTE OF LIFE SCIENCES   (India)

^c King Abdulaziz University   (Saudi Arabia)

Author keywords

Dynamics simulations; EMSA; Molecular docking; NFkB; Resveratrol; RVS(a)

Indexed keywords

DYNAMICS SIMULATION; EMSA; MOLECULAR DOCKING; NFKB; RVS(A);

CELL CULTURE; CELL DEATH; DYNAMICS; MOLECULAR MODELING; RESVERATROL;

BIOACTIVITY;

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; RESVERATROL; RESVERATROL A; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; BIOLOGICAL ACTIVITY; CELL STRAIN U937; DNA FRAGMENTATION; DRUG BINDING SITE; DRUG BIOAVAILABILITY; DRUG DNA BINDING; DRUG SYNTHESIS; GEL MOBILITY SHIFT ASSAY; HUMAN; HUMAN CELL; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR INTERACTION; PLASMA PROTEIN BINDING; PROTEIN DNA BINDING; TUMOR CELL LINE;

CELL LINE, TUMOR; CELL SURVIVAL; CHEMISTRY TECHNIQUES, SYNTHETIC; DNA FRAGMENTATION; HUMANS; MOLECULAR DOCKING SIMULATION; NF-KAPPA B; PROTEIN CONFORMATION; PROTEIN STABILITY; STILBENES;

EID: 84890562409     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-013-0448-z     Document Type: Article

References (46)

1. Aziz, M. H.; Kumar, R.; & Ahmad, N. (2003). International Journal of Oncology, 23, 17-28.
2. Jang, M.; Cai, L.; Udeani, G. O.; Slowing, K. V.; Thomas, C. F.; Beecher, C. W.; Fong, H. H.; Farnsworth, N. R.; Kinghorn, A. D.; Mehta, R. G.; Moon, R. C.; & Pezzuto, J. M. (1997). Science, 275, 218-220.
3. Khan, N.; Afaq, F.; & Mukhtar, H. (2008). Antioxidants & Redox Signaling, 10, 475-510.
4. Pace-Asciak, C. R.; Hahn, S.; Diamandis, E. P.; Soleas, G.; & Goldberg, D. M. (1995). Clinca Chimica Acta, 235, 207-219.
5. Frankel, E. N.; Waterhouse, A. L.; & Kinsella, J. E. (1993). Lancet, 341, 1103-1104.
6. Huang, C.; Ma, W. Y.; Goranson, A.; & Zong, D. (1999). Carcinogenesis, 20, 237-242.
7. Kundu, J. K.; Shin, Y. K.; Kim, S. H.; & Surh, Y. J. (2006). Carcinogenesis, 27, 1465-1474.
8. Mukherjee, S.; Dudley, J. I.; & Das, D. K. (2010). Dose Response, 8, 478-500.
9. Choi, Y. J.; Yang, K. M.; Kim, S. D.; Yoo, Y. H.; Lee, S. W.; Seo, S. Y.; Suh, H.; Yee, S. T.; Jeong, M. H.; & Jo, W. S. (2012). Experimental and Therapeutic Medicine, 3, 592-598.
10. Marier, J.-F.; Vachon, P.; Gritsas, A.; Zhang, J.; Moreau, J. P.; & Ducharme, M. P. (2002). Journal of Pharmacology and Experimental Therapeutics, 302, 369-373.
11. Yu, C.; Shin, Y. G.; Chow, A.; Li, Y.; Kosmeder, J. W.; Lee, Y. S.; Hirschelman, W. H.; Pezzuto, J. M.; Mehta, R. G.; & van Breemen, R. B. (2002). Pharmaceutical Research, 19, 1907-1914.
12. Walle, T.; Hsieh, F.; DeLegge, M. H.; Oatis, J. E.; & Jr Walle, U. K. (2004). Drug Metabolism and Disposition, 32, 1377-1382.
13. Piotrowska, H.; Myszkowski, K.; Ziółkowska, A.; Kulcenty, K.; Wierzchowski, M.; Kaczmarek, M.; Murias, M.; Kwiatkowska-Borowczyk, E.; & Jodynis-Liebert, J. (2012). Toxicology and Applied Pharmacology, 263, 53-60.
14. Fujisawa, S.; & Kadoma, Y. (2006). Chemosphere, 62, 71-79.
15. Zhang, L.; Jing, H.; Cui, L.; Li, H.; Zhou, B.; Zhou, G.; & Dai, F. (2013). Journal of Cellular Biochemistry, 114, 697-707.
16. Mayhoub, A. S.; Marler, L.; Kondratyuk, T. P.; Park, E. J.; Pezzuto, J. M.; & Cushman, M. (2012). Bioorgnic Medicinal Chemistry, 20, 510-520.
17. Jeong, S. H.; Jo, W. S.; Song, S.; Suh, H.; Seol, S. Y.; Leem, S. H.; Kwon, T. K.; & Yoo, Y. H. (2009). Biochemical. Pharmacology, 77, 1337-1347.
18. Lipinski, C. A. (2000). Journal of Pharmacological and Toxicological Methods, 44, 235-249.
19. Lipinski, C. A.; Lombardo, F.; Dominy, B. W.; & Feeney, P. J. (1997). Advanced Drug Delivery Reviews, 23, 3-25.
20. Li, A. P.; & Segall, M. (2002). Drug Discovery Today, 7, 25-27.
21. Berg, K.; Hansen, M. B.; & Nielsen, S. E. (1990). Acta Pathologica. Microbiologica et Immunologica Scandinavica, 98, 156-162.
22. Manna, S. K.; Mukhopadhyay, A.; & Aggarwal, B. (2000). Journal of Immunology, 164, 6509-6519.
23. Chan, J. Y.; Phoo, M. S.; Clement, M. V.; Pervaiz, S.; & Lee, S. C. (2008). Cancer Biology & Therapy, 7, 1305-1312.
24. Park, J. W.; Choi, Y. J.; Suh, S. I.; Baek, W. K.; Suh, M. H.; Jin, I. N.; Min, D. S.; Woo, J. H.; Chang, J. S.; Passaniti, A.; Lee, Y. H.; & Kwon, T. K. (2001). Carcinogenesis, 22, 1633-1639.
25. Walsh, G. M.; Grant, D.; Andrew, J.; Wardlaw, J.; Levi-Schaffer, F.; & Moqbel, R. (1998). Journal of Immunological Methods, 217, 153-163.
26. Huxford, T.; Huang, D. B.; Malek, S.; & Ghosh, G. (1998). Cell, 95, 759-770.
27. Berendsen, H. J.; Postma, J. P. M.; VanGunsteren, W. F.; DiNola, A.; & Haak, J. R. (1984). Journal of Chemical Physics, 81, 3584-3590.
28. Lindahl, E.; Hess, B.; & VanDerSpoe, D. (2001). Journal of Molecular Modeling, 7, 306-317.
29. Schüttelkopf, A. W.; & van Aalten, D. M. (2004). Acta Crystallographica Section D: Biological Crystallography, 60, 1355-1363.
30. Morris, G. M.; Huey, R.; Lindstrom, W.; Sanner, M. F.; Belew, R. K.; Goodsell, D. S.; & Olson, A. J. (2009). Journal Computational Chemistry, 16, 2785-2791.
31. Babajan, B.; Chaitanya, M.; Rajsekhar, C.; Gowsia, D.; Madhusudhana, P.; Naveen, M.; Chitta, S. K.; & Anuradha, C. M. (2011). Interdisciplinary Sciences: Computational Life Sciences, 3, 204-216.
32. Hess, B.; Kutzner, C.; Spoel, D. V. D.; & Lindahl, E. (2008). Journal of Chemical Theory and Computation, 4, 435-447.
33. Chandrasekhar, I.; Kastenholz, M.; Lins, R. D.; Oostenbrink, C.; Schuler, L. D.; Tieleman, D. P.; & van Gunsteren, W. F. (2003). European Biophysics Journal, 32, 67-77.
34. Berendsen, H. J. C.; van der Spoel, D.; & van Drunen, R. (1995). Computer Physics Communications, 91, 43-56.
35. Berendsen, H. J. C.; Postma, J.; van Gunsteren, W. F.; & Hermans, J. (1981) In: Intermolecular forces (Pullman, B.; and Reidel, D.; eds), Dordrecht, The Netherland, pp. 331-342
36. Hess, B.; Bekker, H.; Berendsen, H. J. C.; & Fraaije, J. G. E. M. (1997). Journal of Computatinal Chemistry, 18, 1463-1472.
37. Darden, T.; York, D.; & Pedersen, L. (1993). Journal of Chemical Physics, 98, 10089-10092.
38. Essman, U.; Perela, L.; Berkowitz, M. L.; Darden, T.; Lee, H.; & Pedersen, L. G. (1995). Journal of Chemical Physics, 103, 8577-8593.
39. Mukherjee, A.; & Bagchi, B. (2003). Journal of Chemical Physics, 118, 4733-4747.
40. Dong, Z. (2003). Mutatation Research, 523-524, 145-150.
41. Lu, J.; Ho, C. H.; Ghai, G.; & Chen, K. Y. (2001). Carcinogenesis, 22, 321-328.
42. Castello, L.; & Tessitore, L. (2005). Oncology Report, 13, 133-137.
43. Minutolo, F.; Sala, G.; Bagnacani, A.; Bertini, S.; Carboni, I.; Placanica, G.; Prota, G.; Rap Poselli, S.; Sacchi, N.; Macchia, M.; & Ghidoni, R. (2005). Journal of Medicinal Chemistry, 48, 6783-6786.
44. Simoni, D.; Roberti, M.; Invidiata, F. P.; Aiello, E.; Aiello, S.; Marchetti, P.; Baruchello, R.; Eleopra, M.; Di Cristina, A.; Grimaudo, S.; Gebbia, N.; Crosta, L.; & Dieli, M. (2006). Bioorgnic Medicinal Chemistry Letters, 16, 3245-3248.
45. Wen, X.; & Walle, T. (2006). Drug Metabolism and Disposition, 34, 1786-1792.
46. Aggarwal, B. B. (2004). Cancer Cell, 6, 203-208.